Navigation Links
ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day
Date:4/24/2008

NAIROBI, Kenya, April 24 /PRNewswire-USNewswire/ -- A multi-country project called ACTwatch, which will monitor the availability and affordability of effective malaria treatment, will be launched in Nairobi Friday -- World Malaria Day. Over the next five years, ACTwatch, which is funded by a grant from the Bill & Melinda Gates Foundation, will provide ongoing evidence related to access to antimalarials, specifically artemisinin-based combination therapies (ACTs), the most effective malaria treatment on the market. This evidence will inform policy discussions ongoing at both the global and country level to increase access to effective antimalarials for those who need them most.

ACTwatch is being implemented by a consortium of partners led by the nongovernmental organization PSI. Other partners include the London School of Hygiene and Tropical Medicine, United States Pharmacopeia and the market research firm, Nielsen. The project will be carried out in six African countries (Benin, Democratic Republic of Congo, Madagascar, Nigeria, Uganda and Zambia) and two countries in Southeast Asia (Cambodia and one other, yet to be decided upon).

Studies conducted under the auspices of the project will examine the price, availability and quality of different types of antimalarials in shops and health facilities. Studies will also investigate malaria treatment seeking behavior in the community and the functioning of the supply chain for antimalarials as well as look at the effect of government policies on the structure of the antimalarial market in each country. The principal outputs of ACTwatch will be evidence on changes in the availability, affordability and use of ACTs, in all sectors, as well as policy recommendations targeting national and international decision-makers to increase use of ACTs in vulnerable communities.

Over the past two to three years, ACTs have become the malaria treatment of choice and have replaced drugs, such as chloroquine, which have become ineffective due to the emergence of resistant malaria parasites. While ACTs are extremely effective in treating malaria, they are sold for up to 10 times the price of chloroquine. As a result, major donor initiatives, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, have provided funds to individual countries to procure ACTs for supply through public health facilities to treat patients sick with malaria.

While public facilities in most malaria endemic countries provide ACTs at low cost or for free, almost half of all malaria patients access treatment through shops, where many kinds of antimalarials, of varying quality, can be found. Few shops stock ACTs because they are so expensive and most patients continue to buy ineffective malaria treatments because that is all that they can afford. To address this problem, both global and national financing initiatives to subsidize the price of ACTs are underway. ACTwatch will provide ongoing feedback to these programs, and measure the extent to which these initiatives have been successful.

For more information on ACTwatch, visit http://www.actwatch.info

The mission of PSI is to measurably improve the health of poor and vulnerable people in the developing world, principally through social marketing of family planning and health products and services, and behavior change communications. Social marketing engages private sector resources and uses private sector techniques to encourage healthy behavior and make markets work for the poor.


'/>"/>
SOURCE Population Services International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. Broad-based group of physicians calls for improvement in stroke treatment
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. Pill box organizers increase HIV patients adherence and improve viral suppression
5. Treating depression may improve recovery of heart rate variability following coronary syndromes
6. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
7. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
8. Exercise and yoga improves quality of life in women with early-stage breast cancer
9. QI projects may -- or may not -- improve patient safety and outcomes
10. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon ... all over the country. , Outdoor running increases exposure to ultraviolet radiation, a ... increased risk of melanoma, and only half may be adequately protecting themselves with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... San Diego ... ) health care reform plan, has announced his candidacy for the 52nd Congressional District ... and shared in America’s Promise. Coming to this country at age eleven after suffering ...
(Date:8/20/2017)... ... ... State Farm Neighborhood Assist® has named The Southern Maryland Team Anti-Bullying Program ... initiative wins, Gals Lead – Dream Queen Foundation’s signature teen girl program to help ... Calvert and Charles Counties. The program could potentially impact nearly 17,500 female students (49.4 ...
(Date:8/19/2017)... MD (PRWEB) , ... August 18, 2017 , ... ... and Drug Administration Reauthorization Act of 2017, legislation that provides for greater public ... mild to moderate hearing loss to access OTC hearing aids without being seen ...
(Date:8/19/2017)... ... August 19, 2017 , ... Parker at Stonegate, an assisted ... passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way ... time to refresh the carpeting with the goal of maintaining the same precise ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... DUBLIN, Aug. 8, 2017   ... $3.12 diluted (GAAP) loss per share from continuing operations ... Products revenues increased 16 percent to $110 million ... increased 27 percent to $161 million ... (EPS) from continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: